Scientific Advisory Board

Terry J. Fry, M.D. Faculty and Director of Cancer Immunotherapy, University of Colorado Before joining the Anschutz Medical Campus community, Dr. Fry was a Tenure-Track Investigator at the Pediatric Oncology Branch of the National Cancer Institute. Prior to that, he served as Chief of Blood and Marrow Transplantation at Children’s National Medical Center, a position he…

Scientific Advisory Board

Alex Zukiwski, Ph.D. Oncology clinical development executive Dr. Zukiwski has held many leadership roles in global oncology drug development and has supported the clinical evaluation, regulatory affairs, and registration of many successful therapeutic agents, including Taxotere, Xeloda, Procrit/ Eprex, Velcade, Yondelis, and Doxil in companies such as CASI Pharmaceuticals, Arno Therapeutics, MedImmune, Johnson and Johnson, Centocor…

Scientific Advisory Board

Crystal Mackall, M.D. Professor, Stanford University School of Medicine Crystal Mackall, M.D., is a professor of pediatrics and medicine at Stanford University School of Medicine, where she also leads the Cancer Immunology and Immunotherapy Program and serves as associate director of the Stanford Cancer Institute. Between 1998 and 2016, she was at the National Institutes…

Scientific Advisory Board

Daniel D. Von Hoff, M.D., F.A.C.P. Daniel D. Von Hoff, M.D., F.A.C.P., is currently Physician in Chief, Distinguished Professor Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Senior Consultant, Clinical Investigations for the City of Hope; Chief Scientific Officer for HonorHealth Research Institute; Medical Director of Research, Chief Scientific…

Dr. Michael (Yanhui) Ma, M.D. Dr. Ma is a seasoned scientist, physician, and entrepreneur.  After graduating from medical school in China, Dr. Ma continued his medical studies and research at University of California, San Francisco Medical School, under the mentorship of world renowned professors in Endocrinology, Dr. Gerald Grodsky and Dr. John Karam. Following his medical training, Dr. Ma joined Genentech as a research scientist in the department of Endocrinology at Genentech.  Subsequently, Dr. Ma…

Scientific Advisory Board

Robert F. Siliciano, M.D., Ph.D. Robert F. Siliciano’s childhood love of chemistry was literally fueled by his mother, Ann, an anatomy and physiology professor at Elmira College. “I had a lab in the attic, and my mom would get chemicals for me,” he said. “I had liters of ether and benzene, concentrated hydrochloric acid, toluene.…

Scientific Advisory Board

Cohava Gelber, PhD, MBA Cohava Gelber, PhD, MBA, is an executive with over 25 years of experience in discovery and development of immune therapeutics and diagnostics for cancer, autoimmune disease, allergies and infectious diseases.  Dr. Gelber held various executive positions in academia (Duke University) and biopharmaceutical companies (ImmuLogic Pharmaceutical Corporation, Molecular Discoveries and MannKind Corporation).…

Clinton Severson Board of Directors

Clinton H. Severson, Chairman and Chief Executive Officer, Abaxis Inc. Mr. Clinton Severson serves as the Chairman and Chief Executive Officer of Abaxis Inc. (NASDAQ: ABAX), which develops and sells point-of-care blood laboratory systems for medical and veterinary diagnostic applications. He has over 30 years’ experience in the healthcare and medical diagnostics industry. Prior to Abaxis,…

Ephraim Vidal Ph.D. Leadership

Ephraim Vidal, Ph.D., Director of Pharmaceutical Development Dr. Vidal has sixteen years of experience in the pharmaceutical industry as a pharmaceutical development scientist.  He has led the development of drug substance manufacturing from the early stages through commercial manufacturing. He has worked for Aventis, Sanofi-Aventis and Hospira in various drug substance process development roles.  Dr.…

Stephen Becker, M.D., Chief Scientific and Medical Officer Dr. Becker’s career in HIV began in the early 1980s while a faculty member at UCSF where he led a large HIV clinical practice and clinical research program.  His areas of research include pharmacology and pharmacogenetics, early stage drug development, clinical designs, and HIV health service outcomes…